Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 4:57 pm Unchanged | 13G | RECURSION PHARMACEUTICALS INC. RXRX | VANGUARD GROUP INC | 24,272,798 8.820% | 0 (Unchanged) | View |
2024-11-12 10:34 am Sale | 13G | RECURSION PHARMACEUTICALS INC. RXRX | FMR LLC | 8,363,529 3.040% | -2,533,757 (-23.25%) | View |
2024-11-08 2:17 pm Unchanged | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BlackRock Inc. | 20,742,797 7.500% | 0 (Unchanged) | View |
2024-11-04 4:16 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | Kinnevik AB (publ) | 11,905,668 4.300% | 1,500,000 (+14.42%) | View |
2024-11-04 1:27 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | VANGUARD GROUP INC | 24,272,798 8.820% | 8,607,588 (+54.95%) | View |
2024-10-22 3:24 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BlackRock Inc. | 20,742,797 7.500% | 20,742,797 (New Position) | View |
2024-10-18 10:59 am Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | STATE STREET CORP STT | 12,870,272 4.700% | 718,626 (+5.91%) | View |
2024-07-08 4:17 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.900% | 15,384,615 (New Position) | View |
2024-02-13 5:12 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | VANGUARD GROUP INC | 15,665,210 7.520% | 5,607,847 (+55.76%) | View |
2024-02-12 12:21 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | ARK Investment Management LLC | 23,076,052 11.080% | 2,421,765 (+11.73%) | View |
2024-02-09 09:49 am Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | FMR LLC | 10,897,286 5.231% | 10,897,286 (New Position) | View |
2024-01-29 5:25 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BlackRock Inc. BLK | 12,393,872 6.000% | 1,726,248 (+16.18%) | View |
2024-01-29 4:00 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | ARK Investment Management LLC | 20,654,287 9.920% | 20,654,287 (New Position) | View |
2024-01-26 10:49 am Sale | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BAILLIE GIFFORD & CO | 24,179,504 11.610% | -641,346 (-2.58%) | View |
2024-01-24 10:13 am Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | STATE STREET CORP STT | 12,151,646 5.830% | 12,151,646 (New Position) | View |
2023-05-22 4:05 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | Kinnevik AB (publ) | 10,405,668 5.600% | 10,405,668 (New Position) | View |
2023-02-14 4:05 pm Sale | 13G | RECURSION PHARMACEUTICALS INC. RXRX | Lux Capital Management LLC | 6,004,722 3.300% | -7,016,797 (-53.89%) | View |
2023-02-09 11:30 am Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | VANGUARD GROUP INC | 10,057,363 5.540% | 10,057,363 (New Position) | View |
2023-02-03 12:10 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BlackRock Inc. BLK | 10,667,624 5.900% | 10,667,624 (New Position) | View |
2023-01-24 07:35 am Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | BAILLIE GIFFORD & CO | 24,820,850 13.660% | 2,697,695 (+12.19%) | View |